Pfizer Latest News, Photos and Videos

Russia's Sputnik V to cost lower than Pfizer, Moderna's Covid vax

World | Nov 22, 2020, 08:24 PM IST

Russia's Sputnik V vaccine against Covid-19 will cost governments much lower than that of Pizer's and Moderna's, the official Twitter handle of the world's first registered vaccine against the pandemic said on Sunday.

Pfizer seeking emergency use of its COVID-19 vaccine in US

World | Nov 20, 2020, 05:47 PM IST

Pfizer said Friday it is asking U.S. regulators to allow emergency use of its COVID-19 vaccine, starting the clock on a process that could bring limited first shots as early as next month and eventually an end to the pandemic -- but not until after a long, hard winter.

pfizer vaccine, biontech vaccine, pfizer biontech vaccine deliveries, vaccine deliveries, christmas

Pfizer, BioNTech vaccine deliveries could start 'before Christmas'

World | Nov 19, 2020, 08:51 AM IST

Global drugmakers Pfizer and BioNTech on Wednesday said that their coronavirus vaccine was found 95 per cent effective in the final analysis of the Phase 3 trial, making way for the companies to secure emergency authorisation from US regulators. Chances are that the vaccine deliveries could start before Christmas.

Pfizer says COVID-19 vaccine 95% effective, to seek emergency-use authorization

World | Nov 18, 2020, 08:04 PM IST

The Phase 3 study of our COVID-19 vaccine candidate has met all primary efficacy endpoints. The study reached 170 confirmed cases of COVID19, with the vaccine candidate BNT162b2 demonstrating 95% efficacy beginning 28 days after the first dose.

Storage of Pfizer's COVID-19 vaccine challenge for most nations; India examining possibilities: Govt

India | Nov 17, 2020, 10:17 PM IST

The cold-chain requirement for the anti-coronavirus vaccine candidate developed by Pfizer at a temperature of minus 70 degrees Celsius poses a big challenge, but the government is examining the possibilities if at all the vaccine has to be obtained by India, it said on Tuesday.

US aims to distribute Pfizer's coronavirus vaccine from December

Good News | Nov 11, 2020, 09:13 PM IST

The US is planning to start vaccinating the "most vulnerable" from next month if Pfizer's coronavirus vaccine candidate is quickly approved by the drug regulators, US Health Secretary Alex Azar has said.

Keeping Pfizer vaccine at -70 degree Celsius a challenge for India, says AIIMS director

India | Nov 11, 2020, 04:01 PM IST

Delhi AIIMS director on Wednesday said Pfizer's potential coronavirus vaccine has to be kept at minus 70 degrees Celsius, which will be a challenge for developing countries like India.

Pfizer, BioNTech say trial data shows coronavirus vaccine is more than 90% effective in preventing i

COVID-19 vaccine from Pfizer and BioNTech is found to be 90% effective in preventing infection

World | Nov 09, 2020, 05:58 PM IST

US pharmaceutical giant Pfizer and German biotech firm BioNTech said their coronavirus vaccine was more than 90 per cent effective in preventing COVID-19 among those without evidence of prior infection.

Pfizer CEO Albert Bourla to CBS: Will know coronavirus vaccine status by October

World | Sep 14, 2020, 09:06 PM IST

Albert Bourla, the head of pharmaceutical giant Pfizer, which is among the companies developing a coronavirus vaccine, said that there is a "good chance" the company will know whether its vaccine works by the end of October.

Coronavirus vaccine, vaccine shot, coronavirus, vaccine coronavirus, coronavirus vaccine americans,

Americans could get COVID vaccine shot before year-end, Pfizer CEO says

World | Sep 14, 2020, 10:08 AM IST

Pfizer Inc. Chief Executive Officer Albert Bourla said the Americans are "likely" to get a shot of the COVID-19 vaccine by year-end. He expected the vaccine to be deployed before the public in the U.S. before the end of 2020.

Pfizer-BioNTech COVID-19 vaccine shows positive results, on track for regulatory review in October

Pfizer-BioNTech COVID-19 vaccine shows positive results, may get approved by October

Good News | Aug 21, 2020, 11:12 PM IST

Pfizer and BioNTech said the Covid-19 vaccine they are jointly developing is on track to be submitted for regulatory review as early as October, as they released additional data from an early-stage study.

Pfizer-BioNTech vaccine candidate induces immune response in early-phase clinical trial: Study

World | Aug 12, 2020, 04:58 PM IST

According to the study the vaccine candidate is delivered intramuscularly, and enables human cells to produce proteins part of the SARS-CoV-2 receptor-binding domain, against which the immune system is trained to produce antibodies.

Moderna, Pfizer to include HIV-positive volunteers in Phase 3 trials of COVID-19 vaccines

World | Aug 10, 2020, 06:07 PM IST

Moderna and Pfizer (which has partnered with German biotech firm BioNTech to develop a COVID-19 vaccine) have announced that they will be including a limited number of HIV-positive volunteers in the final stage of trials.

Pfizer, BioNTech begin late-stage clinical trail of lead COVID-19 vaccine candidate

World | Jul 28, 2020, 10:54 PM IST

US-based Pfizer and German biotech firm BioNTech have announced the start of a late stage clinical trial of a Covid-19 vaccine jointly developed by the two companies. The Phase 2/3 study will involve up to 30,000 participants between 18 and 85 years of age.

US hands Pfizer, BioNTech $1.95b order for 100m Covid vaccines

World | Jul 22, 2020, 11:42 PM IST

The US government has agreed to pay $1.95 billion for 100 million doses of a potential Covid-19 vaccine jointly developed by Pfizer and BioNTech, the two companies said on Wednesday.

Pfizer, BioNTech's COVID-19 vaccine candidates get FDA's 'fast track' status

World | Jul 13, 2020, 09:15 PM IST

Two experimental COVID-19 vaccine jointly developed by German Biotech firm BioNTech and US pharmaceutical gaint Pfizer have received "fast track" designation from the US drug regulator FDA. The candidates, BNT162b1 and BNT162b2, are the most advanced of the at least four vaccines being assessed by the companies.

Pfizer